Pakistan Pharma Market – Uneven Distribution and Its Impact on Competition and Strategy – Asrar Qureshi’s Blog Post #1320
Pakistan’s pharmaceutical market is highly concentrated, with the top 50 companies holding nearly 90% of sales, leaving many smaller firms struggling. This disparity affects competition, innovation, and talent acquisition. Smaller firms often resort to survival strategies rather than growth, highlighting a need for stronger capabilities rather than just more companies.